Management tracks: Grail taps Juno founder Bishop as CEO; plus Clovis, OncoCyte, Calico
Grail Inc. (Menlo Park, Calif.) hired Hans Bishop as CEO to succeed Jennifer Cook, who also stepped down from the cancer diagnostic company's board, citing family health reasons. Bishop, who has been on Grail’s board since August, is co-founder and former CEO of Juno Therapeutics and executive chair at Sana Biotechnology Inc. (Seattle, Wash.), a position he will retain.
The addition of Bishop was one of several moves Grail announced Thursday. Renée Galá is departing as CFO, while Joshua Ofman is joining as chief of corporate strategy and external affairs. Previously, Ofman was at Amgen Inc. (NASDAQ:AMGN), where he was SVP of global health policy. Maykin Ho has joined Grail’s board as an independent director. Ho is a venture partner at Qiming Venture Partners and a member of the biotech advisory panel of the Hong Kong stock exchange...